Global siRNA Drug Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global siRNA Drug market size will reach Million USD in 2026 and is projected to reach Million USD by 2033, with a CAGR of % (2026-2033). Notably, the China siRNA Drug market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.

The major global  manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of siRNA Drug Include:

Genzyme

Alnylam

Dicerna

Quark Pharmaceuticals

Arrowhead

Exicure

Miragen Therapeutics

Silence

Sylentis

Avidity Biosciences

Dicerna

BioNTech

Moderna Therapeutics

The WhiteOak Group, Inc.

siRNA Drug Product Segment Include:

Givlaari

Patisiran

Givosiran

siRNA Drug Product Application Include:

Single Gene Rare Disease

Protein Deposition Disease

Chronic Liver Disease

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global siRNA Drug Industry PESTEL Analysis

Chapter 3: Global siRNA Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global siRNA Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global siRNA Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global siRNA Drug Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global siRNA Drug Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： siRNA Drug Industry Development Status

Table 4： siRNA Drug Industry Development Trends

Table 5： Global siRNA Drug Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global siRNA Drug Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global siRNA Drug Revenue Market Share by Region (2021-2026)

Table 8： Global siRNA Drug Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global siRNA Drug Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global siRNA Drug Sales by Region (2021-2026) & (K Unit)

Table 11： Global siRNA Drug Sales Market Share by Region (2021-2026)

Table 12： Global siRNA Drug Sales Forecast by Region (2027-2033)  & (K Unit)

Table 13： Global siRNA Drug Sales Market Share Forecast by Region (2027-2033)

Table 14： Global siRNA Drug Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 15： Global siRNA Drug Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 16： Global siRNA Drug Sales Analysis by Type (2021-2026) & (K Unit)

Table 17： Global siRNA Drug Sales Analysis Forecast by Type (2027-2033) & (K Unit)

Table 18： Global siRNA Drug Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 19： Global siRNA Drug Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 20： Global siRNA Drug Sales Analysis by Application (2021-2026) & (K Unit)

Table 21： Global siRNA Drug Sales Analysis Forecast by Application (2027-2033) & (K Unit)

Table 22： Key siRNA Drug Players in North America

Table 23： North America siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 24： North America siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 25： North America siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 26： North America siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 27： North America siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 28： North America siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 29： North America siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 30： North America siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 31： North America siRNA Drug Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 32： North America siRNA Drug Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 33： North America siRNA Drug Sales Market Size by Country (2021-2026) & (K Unit)

Table 34： North America siRNA Drug Sales Market Size by Country (2027-2033) & (K Unit)

Table 35： Key siRNA Drug Players in Europe

Table 36： Europe siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 37： Europe siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 38： Europe siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 39： Europe siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 40： Europe siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 41： Europe siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 42： Europe siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 43： Europe siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 44： Europe siRNA Drug Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 45： Europe siRNA Drug Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 46： Europe siRNA Drug Sales Market Size by Country (2021-2026) & (K Unit)

Table 47： Europe siRNA Drug Sales Market Size Forecast by Country (2027-2033) & (K Unit)

Table 48： Key siRNA Drug Players in China

Table 49： China siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 50： China siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 51： China siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 52： China siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 53： China siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 54： China siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 55： China siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 56： China siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 57： Key siRNA Drug Players in APAC (excl. China)

Table 58： APAC (excl. China) siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 59： APAC (excl. China) siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 60： APAC (excl. China) siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 61： APAC (excl. China) siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 62： APAC (excl. China) siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 63： APAC (excl. China) siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 64： APAC (excl. China) siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 65： APAC (excl. China) siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 66:： APAC (excl. China) siRNA Drug Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 67： APAC (excl. China) siRNA Drug Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 68： APAC (excl. China) siRNA Drug Sales Market Size by Country (2021-2026) & (K Unit)

Table 69： APAC (excl. China) siRNA Drug Sales Market Size Forecast by Country (2027-2033) & (K Unit)

Table 70： Key siRNA Drug Players in Latin America

Table 71： Latin America siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 72： Latin America siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 73： Latin America siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 74： Latin America siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 75： Latin America siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 76： Latin America siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 77： Latin America siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 78： Latin America siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 79： Latin America siRNA Drug Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 80： Latin America siRNA Drug Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 81： Latin America siRNA Drug Sales Market Size by Country (2021-2026) & (K Unit)

Table 82： Latin America siRNA Drug Sales Market Size Forecast by Country (2027-2033) & (K Unit)

Table 83： Key siRNA Drug Players in Middle East & Africa

Table 84： Middle East & Africa siRNA Drug Sales by Type (2021-2026) & (K Unit)

Table 85： Middle East & Africa siRNA Drug Sales by Type (2027-2033) & (K Unit)

Table 86： Middle East & Africa siRNA Drug Revenue by Type (2021-2026) & (US$ Million)

Table 87： Middle East & Africa siRNA Drug Revenue by Type (2027-2033) & (US$ Million)

Table 88： Middle East & Africa siRNA Drug Sales by Application (2021-2026) & (K Unit)

Table 89： Middle East & Africa siRNA Drug Sales by Application (2027-2033) & (K Unit)

Table 90： Middle East & Africa siRNA Drug Revenue by Application (2021-2026) & (US$ Million)

Table 91： Middle East & Africa siRNA Drug Revenue by Application (2027-2033) & (US$ Million)

Table 92： Middle East & Africa siRNA Drug Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 93： Middle East & Africa siRNA Drug Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 94： Middle East & Africa siRNA Drug Sales Market Size by Country (2021-2026) & (K Unit)

Table 95： Middle East & Africa siRNA Drug Sales Market Size Forecast by Country (2027-2033) & (K Unit)

Table 96： Global siRNA Drug Market Sales by Key Manufacturers (2021-2026) & (K Unit)

Table 97： Global siRNA Drug Sales Market Share by Key Manufacturers (2021-2026)

Table 98： Global siRNA Drug Market Revenue by Key Manufacturers (2021-2026) & (US$ Million)

Table 99： Global siRNA Drug Revenue Market Share by Key Manufacturers (2021-2026)

Table 100： Global Average Sales Price by Manufacturers (2021-2026) & (USD/Unit)

Table 101： Global Key Manufacturers Headquarter Location and Key Area Sales

Table 102： Market Mergers & Acquisitions, Expansion

Table 103： Genzyme Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 104： Genzyme siRNA Drug Product Portfolio

Table 105： Genzyme siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 106： Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 107： Alnylam siRNA Drug Product Portfolio

Table 108： Alnylam siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 109： Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 110： Dicerna siRNA Drug Product Portfolio

Table 111： Dicerna siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 112： Quark Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 113： Quark Pharmaceuticals siRNA Drug Product Portfolio

Table 114： Quark Pharmaceuticals siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 115： Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 116： Arrowhead siRNA Drug Product Portfolio

Table 117： Arrowhead siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 118： Exicure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 119： Exicure siRNA Drug Product Portfolio

Table 120： Exicure siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 121： Miragen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 122： Miragen Therapeutics siRNA Drug Product Portfolio

Table 123： Miragen Therapeutics siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 124： Silence Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 125： Silence siRNA Drug Product Portfolio

Table 126： Silence siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 127： Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 128： Sylentis siRNA Drug Product Portfolio

Table 129： Sylentis siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 130： Avidity Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 131： Avidity Biosciences siRNA Drug Product Portfolio

Table 132： Avidity Biosciences siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 133： Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 134： Dicerna siRNA Drug Product Portfolio

Table 135： Dicerna siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 136： BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 137： BioNTech siRNA Drug Product Portfolio

Table 138： BioNTech siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 139： Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 140： Moderna Therapeutics siRNA Drug Product Portfolio

Table 141： Moderna Therapeutics siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 142： The WhiteOak Group, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 143： The WhiteOak Group, Inc. siRNA Drug Product Portfolio

Table 144： The WhiteOak Group, Inc. siRNA Drug Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2026)

Table 145： Upstream Key Raw Material Price List

Table 146： siRNA Drug Raw Material Suppliers and Contact Information

Table 147： siRNA Drug Typical Customer List

Table 148： siRNA Drug Distributors List

Figure 1： siRNA Drug Product Pictures

Figure 2： Givlaari Picture Scope

Figure 3： Patisiran Picture Scope

Figure 4： Givosiran Picture Scope

Figure 5： Single Gene Rare Disease Picture Scope

Figure 6： Protein Deposition Disease Picture Scope

Figure 7： Chronic Liver Disease Picture Scope

Figure 8： Others Picture Scope

Figure 9：Global siRNA Drug Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 10：Global siRNA Drug Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 11：Global siRNA Drug Market Sales and Growth Rate Analysis (2021-2033) &（K Unit）

Figure 12：Global siRNA Drug Market Price Trend Analysis (2021-2033) & (USD/Unit)

Figure 13：Global siRNA Drug Market Size by Region (2021-2033) & (US$ Million)

Figure 14：Global siRNA Drug Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 15：Global siRNA Drug Sales Price by Region (2021-2033) & (K Unit)

Figure 16：North America siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 17：North America siRNA Drug Revenue Market Share by Players in 2025

Figure 18：North America siRNA Drug Sales Market Share by Type (2021-2033)

Figure 19：North America siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 20：North America siRNA Drug Sales Market Share by Application (2021-2033)

Figure 21：North America siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 22：US siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 23：Canada siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 24：Europe siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 25：Europe siRNA Drug Revenue Market Share by Players in 2025

Figure 26：Europe siRNA Drug Sales Market Share by Type (2021-2033)

Figure 27：Europe siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 28：Europe siRNA Drug Sales Market Share by Application (2021-2033)

Figure 29：Europe siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 30：Germany siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 31：France siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 32：United Kingdom siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 33：Italy siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 34：Spain siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 35：Benelux siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 36：China siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 37：China siRNA Drug Revenue Market Share by Players in 2025

Figure 38：China siRNA Drug Sales Market Share by Type (2021-2033)

Figure 39：China siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 40：China siRNA Drug Sales Market Share by Application (2021-2033)

Figure 41：China siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 42：APAC (excl. China) siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 43：APAC (excl. China) siRNA Drug Revenue Market Share by Players in 2025

Figure 44：APAC (excl. China) siRNA Drug Sales Market Share by Type (2021-2033)

Figure 45：APAC (excl. China) siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 46：APAC (excl. China) siRNA Drug Sales Market Share by Application (2021-2033)

Figure 47：APAC (excl. China) siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 48：Japan siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 49：South Korea siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 50：India siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 51：Australia siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 52：Southeast Asia siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 53：Latin America siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 54：Latin America siRNA Drug Revenue Market Share by Players in 2025

Figure 55：Latin America siRNA Drug Sales Market Share by Type (2021-2033)

Figure 56：Latin America siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 57：Latin America siRNA Drug Sales Market Share by Application (2021-2033)

Figure 58：Latin America siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 59：Mexico siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 60：Brazil siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 61：Middle East & Africa siRNA Drug Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 62：Middle East & Africa siRNA Drug Revenue Market Share by Players in 2025

Figure 63：Middle East & Africa siRNA Drug Sales Market Share by Type (2021-2033)

Figure 64：Middle East & Africa siRNA Drug Revenue Market Share by Type (2021-2033)

Figure 65：Middle East & Africa siRNA Drug Sales Market Share by Application (2021-2033)

Figure 66：Middle East & Africa siRNA Drug Revenue Market Share by Application (2021-2033)

Figure 67：Saudi Arabia siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 68：South Africa siRNA Drug Revenue (2021-2033) & (US$ Million)

Figure 69：Global siRNA Drug Sales Market Share by Key Manufacturers in 2025

Figure 70：Global siRNA Drug Revenue Market Share by Key Manufacturers in 2025

Figure 71：Global siRNA Drug Industry Competition Landscape

Figure 72：siRNA Drug Industry Chain Analysis

Figure 73：Bottom-Up and Top-Down Research Methods

Figure 74：Key Interview Objectives

Figure 75：Data Cross Validation